Company Filing History:
Years Active: 2006
Title: Manesh N Desai: Innovator in Selective NPY Antagonists
Introduction
Manesh N Desai is a notable inventor based in Nutley, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on selective antagonists for the NPY (Y5) receptor. His research has the potential to impact treatments for various abnormalities.
Latest Patents
Manesh N Desai holds 1 patent for his invention titled "Selective NPY (Y5) antagonists." This invention focuses on triazine derivatives, bicyclic compounds, and tricyclic compounds that act as selective antagonists for the NPY (Y5) receptor. The patent outlines a pharmaceutical composition that includes a therapeutically effective amount of the compound and a pharmaceutically acceptable carrier. Additionally, it describes a process for creating this pharmaceutical composition, emphasizing its utility in treating conditions by decreasing the activity of the human Y5 receptor.
Career Highlights
Manesh N Desai is associated with H. Lundbeck A/S, where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation in the pharmaceutical industry, particularly in the area of receptor antagonism.
Collaborations
Throughout his career, Manesh has collaborated with esteemed colleagues, including Mohammad R Marzabadi and Wai C Wong. These partnerships have contributed to the advancement of his research and the development of new therapeutic solutions.
Conclusion
Manesh N Desai's contributions to the field of pharmaceuticals, particularly through his patent on selective NPY antagonists, highlight his role as an innovator. His work has the potential to lead to significant advancements in treatment options for various medical conditions.